SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Universe Pharmaceuticals Inc. UPC NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • CN • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Universe Pharmaceuticals Inc. (UPC) 是一家制药 - 专科与仿制药公司，属于医疗保健行业, 目前交易价格为 $3.27. 其SharesGrow评分为 28/100, 表明较弱的投资特征， 7项中通过0项.

估值: UPC 市盈率(P/E)为 -0.5 (S&P 500平均约25).

财务数据: 营收为 $18M, -23.6%/yr 平均增长. 净利润为 $4M (亏损), 增长率为 +15.3%/yr. 净利润率为 -20.6% (负值). 毛利率为 35.3% (-19.2 pp 趋势).

资产负债表: 总债务为 $9M 对比 $56M 股东权益 (D/E比率 0.16, 保守). 流动比率为 4.07 (流动性强). 资产负债率为 13.4%. 总资产: $69M.

SharesGrow 7项标准细分: Value ?/100 (Fail), Growth 48/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 21/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

UPC SharesGrow 评分概览

37/100

SharesGrow Score

Below average — proceed with caution

View full scorecard →

价值 0/100

估值 — P/E, PEG, Forward PEG

成长 48/100

财务数据 — 平均增长

过去 0/100

强劲 — 趋势

健康 67/100

资产负债表 — D/E比率, 流动比率为

护城河 21/100

毛利率为 + market cap

未來 0/100

分析师展望 — 为买入

收入 10/100

净利润率为

Scores derived from financial statements, analyst ratings, and balance sheet data.

评分明细 — UPC

No analyst coverage available for this stock.

UPC: -23.6%/yr 营收为, +15.3%/yr 净利润为平均增长. 一般. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

No analyst coverage available for this stock.

资产负债表 UPC: D/E比率 0.16 (保守), 流动比率为 4.07 (流动性强). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

UPC: 毛利率为 35.3% (-19.2 pp 趋势), N/A market cap. Moat (0-100): margin (35%) + 趋势 (15%) + market cap (30%) + 营收为 (20%). Score 21/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

UPC: 净利润率为 -20.6%. 负值. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

股票图表与统计

市场数据

52周区间2-11

成交量1.19K

30日平均成交量9.24K

市值$1.84M

Beta（1年）1.48

股份统计

EPS（TTM）-1,055.75

流通股数$3.48K

IPO日期2021-03-23

员工数225

首席执行官Gang Lai

财务亮点与比率

营收（TTM）$17.86M

毛利润$6.3M

EBITDA$-2.92M

净利润$-3.67M

营业利润$-2.92M

现金总额$33.59M

总负债$9.26M

净负债$-24.34M

总资产$69.3M

市盈率（P/E）-0

市销率（P/S）0.1

分析师预测

公司信息

国家CN

交易所NASDAQ Global Market

货币USD

ISINKYG9442G1385

股价走势

UPC

Universe Pharmaceuticals Inc. ↗ · NASDAQ Global Market

Healthcare • Drug Manufacturers - Specialty & Generic

2.00 52周区间 11.00

其他人也在看

Regencell Bioscience Holdings Limited

Phibro Animal Health Corporation

Sihuan Pharmaceutical Holdings Group Ltd.

Alpha Teknova, Inc.

Procaps Group S.A.

Silver Spike Investment Corp.

Qilian International Holding Group Limited

Procaps Group, S.A.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言